Actuate Therapeutics, Inc. Total Liabilities and Equity
Actuate Therapeutics, Inc. (ACTU) had Total Liabilities and Equity of $5.20 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $5.20M.
- 2026-03-31: Liabilities and Equity $8.91M.
- 2025-12-31: Liabilities and Equity $14.04M.
- 2025-09-30: Liabilities and Equity $17.71M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $5.20M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $8.91M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $14.04M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $17.71M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $6.97M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $4.48M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $9.32M 10-K · filed 2026-03-26 |
| 2024-09-30 | $14.26M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.73M 10-Q · filed 2024-09-24 |
| 2023-12-31 | $3.00M 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |